相关实验视频
Updated: Jan 11, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
当阿卡博斯过量剂量变得严重时:在不常见的场景中管理低血糖症
Aron Shrestha1, Navin Poudel1, Kshitiz Acharya1
1Maharajgunj Medical Campus Tribhuvan University Teaching Hospital Kathmandu Nepal.
过量服用阿卡博斯可以导致危险的低血糖症. 在患有无法解释的低血糖患者,特别是患有精神疾病或使用其他降血糖药物的患者中,考虑阿卡尔毒性.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 阿卡尔是一种α-葡萄糖酶抑制剂,用于治疗2型糖尿病.
- 虽然通常是安全的,但阿卡尔过量服用存在重大风险.
研究的目的:
- 为了突出由于阿卡尔过量服用而导致严重低血糖的可能性.
- 强调在特定患者群体中考虑阿卡尔毒性的重要性.
主要方法:
- 临床病例审查和分析与阿卡尔相关的不良事件数据.
- 关于阿卡尔毒性和管理策略的文献综述.
主要成果:
- 过量服用阿卡博斯可以导致严重的,危及生命的低血糖症.
- 患有精神疾病或接触其他低血糖药物的患者的不明原因低血糖症需要考虑阿卡尔毒性.
结论:
- 迅速识别和管理阿卡尔过量是非常重要的.
- 静脉注射葡萄糖,警监测和患者教育对于成功治疗和预防复发至关重要.
更多相关视频
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
相关概念视频
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Acute Pancreatitis II: Clinical Manifestations and Management
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Oral Hypoglycemic Agents: Glinides